Home / Piperacillin and Beta-Lactamase Inhibitor / Belgium
BE ATC J01CR05 · updated 2 Nov 2026
Piperacillin and Beta-Lactamase Inhibitor shortage in Belgium
Is there a Piperacillin and Beta-Lactamase Inhibitor shortage in Belgium?
Yes. As of 2 Nov 2026, 2 Piperacillin and Beta-Lactamase Inhibitor products are reported short in Belgium, the first since 20 Jul 2023. The company estimate for the return is 1 Mar 2027. Main reason: other.
Also short in United States, Canada, Italy, Switzerland, Czechia, Sweden, Japan. All countries.
Affected products in Belgium
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| BE | Piperacillin/Tazobactam Eugia 2 g - 250 mg inf. sol. (pwdr.) i.v. vial 10 (2 g - 250 mg) | Eugia Pharma (Malta) | 20 Jul 2023 | 1 Mar 2027 | Other Other reason |
| BE | Piperacillin/Tazobactam Eugia 4 g - 500 mg inf. sol. (pwdr.) i.v. vial 10 (4 g - 500 mg) | Eugia Pharma (Malta) | 20 Jul 2023 | 1 Mar 2027 | Other Other reason |
Source
FAMHP (Federal Agency for Medicines and Health Products), PharmaStatus / SAMv2. Official list. All authorised packs with a declared temporary unavailability.